Seroba Lifesciences is a European life sciences venture capital firm focused on investing in innovations in biotech and medtech.

Seroba Lifesciences

MedTech World is a global event management company that organizes an annual investor and entrepreneur conference in the medtech and health tech sector in Malta, along with multiple roadshow events worldwide. It fosters collaboration among stakeholders to enhance healthcare.

MedTech World

Seroba. | 3,564 followers on LinkedIn. A leading European life sciences venture capital firm. | Investing in life sciences. Investing in life.

Seroba is a European life sciences venture capital firm based in Dublin and Paris, investing its fourth Fund.

Seamus O´Hara

Partner, Investor Relations, Seroba

Maud Lazare

Partner & CFO at Seroba Life Sciences

Andrew Duignan FCA, AITI, QFA, BA (Hons)

Partner at Seroba.

Jennifer McMahon

Seroba.

Another great opportunity in the portfolio with Loci Orthopaedics ! #SerobaVC #Regulatory #Medtech

Seroba portfolio company ShiraTronics, Inc. is hiring a Vice President of Finance in Ireland! Head over to the #ShiraTronics 's page to check out the job post and learn more about this exciting opportunity and help to transform the lives of patients with chronic migraine. #Medtech #Finance #NewJob #Hiring

Alan O'Connell and Daniel O'Mahony , partners at Seroba. , were delighted to attend the Goodbody celebration of 150 years serving its clients at the beautiful Examination Hall in Trinity College Dublin last night. Bryan Dobson hosted the night with a discussion on how the Irish economy has transformed over recent decades and how we can we continue to build ongoing growth and prosperity with Colin Hunt, CEO, AIB and Frank O'Connor, CEO of National Treasury Management Agency followed by an insightful discussion on the potential transformative impact of AI on the economy. Thank you to Martin Tormey who walked us through the story of how Robert Goodbody founded the firm in 1874 and how it has grown and thrived over the intervening years and to the Goodbody team for hosting a great evening and congratulations on your 150th! Alan Mahon Cathy Bryce Finlay McFadyen Richard Morton Don Harrington Simon Howley

We are down to our final slots with Office Hours in PorterShed supported by AIB on the 19th November, make sure to grab your slot soon to avoid missing out on this opportunity to meet Jennifer McMahon and Sophie Hughes, PhD to discuss your start-up!

Quanta Dialysis Technologies , a Seroba. portfolio company, received FDA Clearance for home hemodialysis system. This is another milestone for them, expanding further its product offering in the U.S; in hospitals, in-centre clinics, and now in the patient’s home. Seroba are committed to bring accessible care to more patients.

Delighted to announce that Jennifer McMahon and Sophie Hughes, PhD from Seroba. will be attending Office Hours in PorterShed supported by AIB on the 19th November from 11am - 4pm. Anyone looking for advice or the right investment partner within the Medtech/Biotech space, book a space here: https://lnkd.in/ew93-qcQ #Officehours #venturecapital #investmentadvice

Sophie Hughes, PhD , investment analyst at Seroba. will be a part of this Level 20 Ireland outreach event on the 7th October. We would recommend anyone looking at getting involved in a career in venture capital to register. Places are limited! RSVP at https://lnkd.in/e_weqJNh Sign up for a FREE Level 20 Student Membership here https://lnkd.in/eCv_E3w7 #diversity #genderequity #careerprogression #venturecapital

Seroba. was attending #UglyDuck24 , the annual gathering of VC GPs by the European Investment Fund (EIF) . Some key highlights - The CEO, Marjut Falkstedt , call for EIF and VC partners to be agents of change to advance innovation, sustainability and diversity - The important Mario Draghi report which outlined the need for €800b investment p.a. in innovation to drive European growth, productivity and competitiveness https://lnkd.in/ehCNzKk8 - Venture capital is a key driver of innovation and if Europe is to meet its innovation and competitiveness goals it will require a significant increase in the €14b European venture capital it raised in 2023. -"This will not happen in real life without VC"- Uli Grabenwarter , Director of Equity Investments. Thank you to European Investment Fund (EIF) team. Patric Gresko Johannes Virkkunen Nick Dunster European Commission #Innovation #EuropeanVC #EIF #UglyDuck24 #LifeSciences #Seroba

Proud of our portfolio company, Shorla Oncology . Shorla Oncology’s Mission is to make existing oncology treatments better through formulation re-innovation. Thank you to Shorla Team. Sharon Cunningham Orlaith Ryan Rayna Herman #BreastCancerAwareness #Innovation #Seroba

We were glad to have attended last night's HPSU Founders Forum Founder of the Year award ceremony. Enterprise Ireland Chairman, Michael Carey "The Founder of the Year Awards promotes Ireland’s ecosystem of entrepreneurs who have displayed the potential and commitment to building their businesses and set their sights on global markets." And as executive director Jenny Melia put it, the night was filled with stories of passion and resilience in a room full of people determined to be the change. Congratulations to all of the nominated founders.

Metric
Company Name	Seroba Lifesciences	MedTech World
Symbol
MSH ID	COM:SEROBAVC	WORLD:MED-TECH
Market	PRIVATE	PRIVATE
Sector	Financial Services & Finance	Commercial & Professional Services
Industry	Venture Capital	Event Management
Country	IE	MT
Stage
Employee Count
Website	serobavc.com	med-tech.world
LinkedIn	serobavc	mtw-medtech-world
Founders

Metric
Market Cap
Enterprise Value
Monthly Web Traffic
Web Traffic Growth
Valuation
Raised Capital

Metric
Revenue
Revenue (LTM)
Revenue (NTM)
Gross Profit
EBITDA
Operating Income
Net Income
EPS
Diluted EPS
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score
28-Day Growth Score
90-Day Growth Score
365-Day Growth Score

Metric
Gross Profit Margin
Operating Profit Margin
EBITDA Margin
Net Profit Margin
Return on Equity
Return on Assets
Return on Capital Employed

SERO

COM:SEROBAVC

Seroba Lifesciences

Company Overview

Market Metrics

Financial Performance

Growth Metrics

Profitability Ratios

Valuation Multiples

Operational Metrics

Cash Flow Metrics

Balance Sheet Metrics

Efficiency Metrics

Metric
P/E Ratio
P/B Ratio
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio
EV Multiple

Metric
Days Sales Outstanding
Days Payables Outstanding
Days Inventory Outstanding
Operating Cycle
Cash Conversion Cycle
Asset Turnover

Metric
Operating Cash Flow
Free Cash Flow
Cash Flow to Debt
Operating Cash Flow/Sales
Free Cash Flow Yield

Metric
Cash & Equivalents
Accounts Receivable
Inventory
Goodwill
Debt to Capitalization
Debt to Assets
Current Ratio
Quick Ratio

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue
R&D to Revenue
SG&A to Revenue